EDITORIAL
Accepted on 10 Jun 2025
Editorial: Immunotherapy Resistance and Advancing Adaptive Cell Therapeutics
doi 10.3389/fimmu.2025.1640317
- 200 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Immunotherapy Resistance and Advancing Adaptive Cell Therapeutics
Immunotherapy Resistance and Advancing Adaptive Cell Therapeutics
8,506
Total downloads
31k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 22 Apr 2025
Advancing personalized, predictive, and preventive medicine in bladder cancer: a multi-omics and machine learning approach for novel prognostic modeling, immune profiling, and therapeutic target discovery
doi 10.3389/fimmu.2025.1572034
- 1,900 views
MINI REVIEW
Published on 28 Mar 2025
γδT cells, a key subset of T cell for cancer immunotherapy
doi 10.3389/fimmu.2025.1562188
- 2,183 views
REVIEW
Published on 21 Mar 2025
New player in CAR-T manufacture field: comparison of umbilical cord to peripheral blood strategies
doi 10.3389/fimmu.2025.1561174
- 1,995 views
- 1 citation
MINI REVIEW
Published on 12 Feb 2025
Advancing biliary tract malignancy treatment: emerging frontiers in cell-based therapies
doi 10.3389/fimmu.2025.1559465
- 2,374 views
MINI REVIEW
Published on 05 Feb 2025
Advancements in cellular immunotherapy: overcoming resistance in lung and colorectal cancer
doi 10.3389/fimmu.2025.1554256
- 3,082 views
- 1 citation
REVIEW
Published on 14 Jan 2025
Prognostic significance of programmed cell death 1 expression on CD8+T cells in various cancers: a systematic review and meta-analysis
doi 10.3389/fonc.2024.1531219
- 735 views
REVIEW
Published on 29 Nov 2024
Breaking barriers: advancing cellular therapies in autoimmune disease management
doi 10.3389/fimmu.2024.1503099
- 3,117 views
- 2 citations
ORIGINAL RESEARCH
Published on 24 Jun 2024
CXCR4 has a dual role in improving the efficacy of BCMA-redirected CAR-NK cells in multiple myeloma
doi 10.3389/fimmu.2024.1383136
- 4,429 views
- 5 citations
CASE REPORT
Published on 11 Jun 2024
Hemophagocytic lymphohistiocytosis/cytokine release syndrome secondary to neoadjuvant pembrolizumab for triple-negative breast cancer: a case study
doi 10.3389/fonc.2024.1394543
- 1,767 views
- 3 citations
ORIGINAL RESEARCH
Published on 19 Apr 2024
Scrutiny of chimeric antigen receptor activation by the extracellular domain: experience with single domain antibodies targeting multiple myeloma cells highlights the need for case-by-case optimization
doi 10.3389/fimmu.2024.1389018
- 3,118 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Vaccines and Molecular Therapeutics
T Cell Biology
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore